Latest

• Cefpodoxime proxetil – new opportunities in antibacterial therapy of respiratory infections

  Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(4):366-371

• Differential diagnosis of community-acquired bacterial pneumonia and viral lung injury in hospitalized adults

  Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(3):297-303

• Patterns of antibiotic use in the population of various regions of the Russian Feder ation: a qualitative, comparative analysis

  Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(3):247-259

• Infective endocarditis caused by Klebsiella pneumoniae in a patient with non ST elevation myocardial infarction

  Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(1):100-105

• Patterns of antimicrobial dispensing in community pharmacies in Russia during the COVID-19 pandemic

  Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(1):84-92

• Invasive aspergillosis in patients with COVID-19 in intensive care units: results of a multicenter study

  Clinical Microbiology and Antimicrobial Chemotherapy. 2022; 24(4):295-302

• Microbiological monitoring of COVID-19 patients in the ICU: a prospective observational study

  Clinical Microbiology and Antimicrobial Chemotherapy. 2022; 24(3):274-282

• Consumption of systemic antibiotics in the Russian Federation in 2017–2021

  Clinical Microbiology and Antimicrobial Chemotherapy. 2022; 24(3):220-225

• Official statements of the expert meeting on pneumococcal vaccination in adults in Russia

  Clinical Microbiology and Antimicrobial Chemotherapy. 2021; 23(2):161-165

• Potential for the use of macrolides in the antimicrobial therapy of severe community-acquired pneumonia in adults

  Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(3):217-223

• Vaccination against pneumococcal infections in adults

  Clinical Microbiology and Antimicrobial Chemotherapy. 2018; 20(1):5-8

• Infectious endocarditis caused by Gemella haemolysans: clinical issues and treatment approaches

  Clinical Microbiology and Antimicrobial Chemotherapy. 2017; 19(4):335-340

• Potential of the Introduction of Tedizolid for the Treatment of Complicated Skin and Soft Tissue Infections in a Russian Multi-Field Hospital

  Clinical Microbiology and Antimicrobial Chemotherapy. 2016; 18(3):174-185

• Paediatricians Approach to Prescribing of Systemic Antimicrobials in Outpatient Children with Upper Respiratory Tract and ENT Infections: Data from Multicenter Survey

  Clinical Microbiology and Antimicrobial Chemotherapy. 2016; 18(1):20-32

• Clinical Guidelines on Diagnosis, Treatment and Prophylaxis of Severe Community-Acquired Pneumonia in Adults

  Clinical Microbiology and Antimicrobial Chemotherapy. 2015; 17(2):84-126

• Clinico-Economic Effectiveness of Ceftaroline Fosamil for the Treatment of Hospitalised Patients with Pneumococcal Community-Acquired Pneumonia from a Societal Perspective

  Clinical Microbiology and Antimicrobial Chemotherapy. 2015; 17(1):33-51

• Systemic Antimicrobials Consumption and Expenditures in Intensive Care Units of Hospitals in Russian Federation and Republic of Belarus: Results of Multicenter Pharmacoepidemiological Study

  Clinical Microbiology and Antimicrobial Chemotherapy. 2014; 16(4):294-311

• Community-Acquired Pneumonia Caused by Mycoplasma pneumoniae: Literature Review and Results of the Regional Study

  Clinical Microbiology and Antimicrobial Chemotherapy. 2013; 15(1):4-13

• Systemic Antimicrobials Consumption and Expenditures in Multi-Profile Hospitals in Russian Federation and Republic of Belarus: the Results of Multicenter Pharmacoepidemiological Trial

  Clinical Microbiology and Antimicrobial Chemotherapy. 2012; 14(4):322-341

• Comparative Clinical and Pharmacoeconomic Analysis of Different Antimicrobial Treatment Regimens in Hospitalized Patients with Community-Acquired Pneumonia

  Clinical Microbiology and Antimicrobial Chemotherapy. 2012; 14(3):209-221

• Efficacy of Intervention Campaign in Outpatients with Acute Tonsillopharyngitis in Smolensk

  Clinical Microbiology and Antimicrobial Chemotherapy. 2011; 13(1):46-55

• Community-Acquired Pneumonia in Adults: Guidelines on the Diagnosis, Treatment and Prevention

  Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(3):186-125

• Patterns of Antibacterial Therapy of Community-Acquired Pneumonia in Hospitalized Adults in Different Regions of Russia: Lessons from Multicentre Pharmacoepidemiology Study

  Clinical Microbiology and Antimicrobial Chemotherapy. 2009; 11(1):66-78

• Guidelines on Diagnosis and Treatment of Legionella pneumophila Serogroup 1 Infection

  Clinical Microbiology and Antimicrobial Chemotherapy. 2009; 11(1):4-13

• Antimicrobial Susceptibility of Causative Agents of Fatal Community-Acquired Pneumonia in Adult Patients

  Clinical Microbiology and Antimicrobial Chemotherapy. 2008; 10(4):368-380

• Analysis of Outpatient Use of Systemic Antimicrobials in Different Regions of Russia

  Clinical Microbiology and Antimicrobial Chemotherapy. 2008; 10(1):59-69

• Community-Acquired Pneumonia in Adults: Guidelines on Diagnosis, Treatment and Prophylaxis

  Clinical Microbiology and Antimicrobial Chemotherapy. 2006; 8(1):54-86

• Clarithromycin: is There Potential for Clinical Use in the 21th Century?

  Clinical Microbiology and Antimicrobial Chemotherapy. 2005; 7(4):369-392

• Drug Therapy of Acute Otitis Media in Adult Outpatients: Results of the Multicenter Pharmacoepidemiological Study

  Clinical Microbiology and Antimicrobial Chemotherapy. 2004; 6(2):124-132

• Community – Acquired Pneumonia: Giudelines on Diagnosis, Treatment and Prophylaxis

  Clinical Microbiology and Antimicrobial Chemotherapy. 2003; 5(3):198-224

• Therapy of Exacerbation of Chronic Bronchitis in Ambulatory Practice: the Results of the Pharmacoepidemiological Study

  Clinical Microbiology and Antimicrobial Chemotherapy. 2001; 3(2):148-155

• Antimicrobials Prescription Pattern in Outpatient Adults with Community-Acquired Pneumonia

  Clinical Microbiology and Antimicrobial Chemotherapy. 2000; 2(3):74-81